(Q36351758)

English

Montelukast and fluticasone compared with salmeterol and fluticasone in protecting against asthma exacerbation in adults: one year, double blind, randomised, comparative trial

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Montelukast and fluticasone compared with salmeterol and fluticasone in protecting against asthma exacerbation in adults: one year, double blind, randomised, comparative trial (English)

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

0 references

object named as

Hans Bisgaard

2

0 references

Stephen T. Holgate

7

object named as

Stephen T Holgate

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

1

object named as

Leif Bjermer

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

6

object named as

Tari Haahtela

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

3

object named as

Jean Bousquet

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Leonardo M. Fabbri

4

object named as

Leonardo M Fabbri

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

author name string

Andrew P Greening

5

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Cesar Picado

8

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Joris Menten

9

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

S Balachandra Dass

10

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Jonathan A Leff

11

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Peter G Polos

12

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

language of work or name

0 references

publication date

1 October 2003

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

327

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

7420

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

891

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Allergic inflammation and airway smooth muscle function.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=218809

30 September 2017

Granulocyte markers in induced sputum in patients with respiratory disorders and healthy persons obtained by two sputum-processing methods

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=218809

30 September 2017

Effect of oral glucocorticoid treatment on serum inflammatory markers in acute asthma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=218809

30 September 2017

Meta-analysis of increased dose of inhaled steroid or addition of salmeterol in symptomatic asthma (MIASMA).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=218809

30 September 2017

Montelukast: a review of its therapeutic potential in persistent asthma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=218809

30 September 2017

Long-acting beta(2)-agonists in management of childhood asthma: A critical review of the literature

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=218809

30 September 2017

Montelukast added to inhaled beclomethasone in treatment of asthma. Montelukast/Beclomethasone Additivity Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=218809

30 September 2017

Efficacy of inhaled corticosteroids in asthma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=218809

30 September 2017

Effects of montelukast (MK-0476); a potent cysteinyl leukotriene receptor antagonist, on bronchodilation in asthmatic subjects treated with and without inhaled corticosteroids

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=218809

30 September 2017

Effect of oral prednisone on airway inflammatory mediators in atopic asthma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=218809

30 September 2017

Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=218809

29 June 2018

Reduction of eosinophilic inflammation in the airways of patients with asthma using montelukast

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=218809

22 September 2018

Clinical outcome of adding long-acting beta-agonists to inhaled corticosteroids

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=218809

22 September 2018

Salmeterol powder provides significantly better benefit than montelukast in asthmatic patients receiving concomitant inhaled corticosteroid therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=218809

22 September 2018

Evaluation of salmeterol or montelukast as second-line therapy for asthma not controlled with inhaled corticosteroids

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=218809

22 September 2018

Regulation of TNF-alpha-induced eotaxin release from cultured human airway smooth muscle cells by beta2-agonists and corticosteroids

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=218809

22 September 2018

Treatment of asthma with drugs modifying the leukotriene pathway.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=218809

22 September 2018

Determining a minimal important change in a disease-specific Quality of Life Questionnaire.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=218809

22 September 2018

ICH Harmonised Tripartite Guideline. Statistical principles for clinical trials. International Conference on Harmonisation E9 Expert Working Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/14563743

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fluticasone propionate/salmeterol combination provides more effective asthma control than low-dose inhaled corticosteroid plus montelukast

1 reference

https://pubmed.ncbi.nlm.nih.gov/14563743

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Distal lung dysfunction at night in nocturnal asthma

1 reference

https://pubmed.ncbi.nlm.nih.gov/14563743

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differential effects of fluticasone propionate on allergen-evoked bronchoconstriction and increased urinary leukotriene E4 excretion

1 reference

https://pubmed.ncbi.nlm.nih.gov/14563743

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Allen & Hanburys Limited UK Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/14563743

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Eosinophil inflammation in asthma

1 reference

https://pubmed.ncbi.nlm.nih.gov/14563743

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids

1 reference

https://pubmed.ncbi.nlm.nih.gov/14563743

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inflammation in asthma: the cornerstone of the disease and target of therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/14563743

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Montelukast versus salmeterol in patients with asthma and exercise-induced bronchoconstriction. Montelukast/Salmeterol Exercise Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/14563743

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Montelukast reduces airway eosinophilic inflammation in asthma: a randomized, controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/14563743

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1136/BMJ.327.7420.891

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36351758&oldid=2070127259"